HLA class II allelic variation and susceptibility to pemphigus vulgaris. 1988

S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
Department of Human Genetics, Cetus Corporation, Emeryville, CA 94608.

The autoimmune dermatologic disease pemphigus vulgaris (PV) is associated with the HLA serotypes DR4 and DRw6. Susceptibility to PV could be conferred either by sequences shared between the DR4 and DRw6 haplotypes or by different sequences in these haplotypes. We have examined the distribution of DR and DQ beta-chain and DQ alpha-chain alleles in PV patients and in control subjects by hybridization with oligonucleotide probes and sequence analysis of in vitro amplified DNA. Ninety percent (34/38) of the DR4 haplotypes in patients contain a specific DR beta I sequence present in 36% (16 of 44) of DR4 controls (P = 0.001). This sequence is also found in DRw6 haplotypes. However, it is present in only 25% (6 of 24) of DRw6 patients. The results of our analysis indicate that predisposition to PV is conferred by different sequences in DR4 and DRw6 haplotypes. The DR4 susceptibility is highly associated with the Dw10 DR beta I allele, implicating the polymorphic residues in the third hypervariable region. The DRw6 susceptibility is strongly associated with a rare DQ beta allele (DQB1.3). This allele differs from a common DQ beta allele (DQB1.1) only by a valine----aspartic acid substitution at position 57.

UI MeSH Term Description Entries
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008285 Major Histocompatibility Complex The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Histocompatibility Complex,Complex, Histocompatibility,Complex, Major Histocompatibility,Complices, Histocompatibility,Complices, Major Histocompatibility,Histocompatibility Complex, Major,Histocompatibility Complices,Histocompatibility Complices, Major,Major Histocompatibility Complices
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
December 2014, International journal of dermatology,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
August 1992, Journal of the American Academy of Dermatology,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
October 2006, Actas dermo-sifiliograficas,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
December 1987, Transplantation,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
January 1995, Acta dermato-venereologica,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
August 2000, Journal of autoimmunity,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
January 1999, Medicina,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
August 1989, Proceedings of the National Academy of Sciences of the United States of America,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
September 1998, Tissue antigens,
S J Scharf, and A Friedmann, and C Brautbar, and F Szafer, and L Steinman, and G Horn, and U Gyllensten, and H A Erlich
July 1998, Tissue antigens,
Copied contents to your clipboard!